eLife Submission Process

This page is about workflow after you decide to submit.

Use it when you want to understand:

• what happens after submission
• how the editorial screen works in the reviewed-preprint model
• when the public assessment appears
• what optional revision and Version of Record steps actually mean

If you still need help deciding whether the package and team are ready for the model, that belongs on the submission-guide page.

The process goes better when the manuscript already behaves like an eLife submission before the portal opens:

• the team is comfortable with preprint-first publication
• the paper can tolerate public critique
• the open-science materials are already in good shape

That is why the workflow question starts before submission.

In a traditional journal, peer review is private and the outcome is a binary accept or reject. At eLife, peer review is public and the outcome is a Reviewed Preprint with transparent feedback.

This means:

• your paper does not get "rejected" in the traditional sense after peer review
• the reviewer feedback and eLife Assessment are published alongside your preprint
• you choose when (or whether) to submit a revised version
• you choose when to convert the Reviewed Preprint into a formal Version of Record

The model separates the peer review function (feedback and evaluation) from the publication decision (which stays with the author). This is a fundamental shift from how most journals operate.

The early stage is not just an editor opinion on scientific quality. Editors are effectively testing whether:

• the paper is significant enough to justify public review
• the evidence is strong enough that a public assessment is worth publishing
• the manuscript fits eLife's life-science scope
• the authors appear to understand the model they are entering

That is why a strong paper can still be a weak eLife submission if the model fit is poor.

eLife only reviews papers that are available as preprints. If you have not posted a preprint, you can do so during the submission process. eLife will ask about preprint status during submission and can facilitate posting to bioRxiv.

This is not negotiable. The entire model depends on the work being publicly available before review.

Before or during submission, ensure the manuscript is publicly available as a preprint. Include the preprint DOI in your submission.

Go to eLife's submission portal. Provide the preprint link, cover letter, author information, and declarations. Select the research area that best matches your work.

A senior editor paired with a reviewing editor evaluates whether the paper should be sent for peer review. They assess:

• significance of the findings within the field
• whether the paper reports results of broad interest
• methodological soundness at a high level
• fit with eLife's editorial scope (biomedical and life sciences)

The editorial screen is the main filter and the most selective step in the process. If your paper passes editorial evaluation, it is very likely to receive a complete Reviewed Preprint with full reviewer feedback and a public eLife Assessment. The important distinction is that the real gating decision happens before review, not after it.

Papers that pass editorial screening go to 2 to 3 reviewers. The reviewers produce individual reports and then collaboratively write the eLife Assessment and Public Review Summary.

The eLife Assessment evaluates two dimensions:

• Significance of findings: landmark, fundamental, important, valuable, or useful
• Strength of evidence: exceptional, compelling, convincing, solid, or incomplete

These terms have specific meanings in eLife's framework and appear publicly alongside the Reviewed Preprint.

Within about 2 weeks of review completion, eLife publishes the Reviewed Preprint on its website. This includes the paper, the eLife Assessment, public review summaries, and the author response (if provided).

This is a citable publication with a DOI. It is not a draft or a provisional version. It is a peer-reviewed preprint with transparent evaluation.

After receiving the reviews, authors can:

• revise the manuscript and submit an updated version for possible re-review
• publish a Version of Record (formal journal article) at any point after review
• leave the Reviewed Preprint as the final publication

There is no fixed deadline for revision. Authors can take as long as needed to address reviewer feedback.

eLife charges $3,000 when the preprint is sent for peer review. This covers the editorial evaluation, peer review, Reviewed Preprint publication, any subsequent re-reviews, and the Version of Record. Fee waivers are available for authors who cannot pay.

The fee is charged regardless of the outcome of peer review. Even if the eLife Assessment is unfavorable, the Reviewed Preprint is published.

The useful question at eLife is not only how many weeks have passed. It is where the paper is inside a model that publishes review outputs publicly.

• early quiet usually means editorial suitability for reviewed-preprint publication is being judged
• active review time means the paper is already on track for public assessment if it stays in the process
• post-review waiting often reflects preparation of the Reviewed Preprint package and assessment materials, not a hidden accept or reject debate

That is why authors should read eLife timing differently from a conventional journal.

An Assessment rating of "incomplete" evidence or "useful" significance is less favorable, but the Reviewed Preprint is still a peer-reviewed publication. Authors can revise and request re-review to improve the Assessment.

Yes. A Reviewed Preprint is a peer-reviewed publication in eLife. The Version of Record is a traditional journal article. Both are citable.

The initial Assessment is published with the first Reviewed Preprint. If authors revise and the revision is re-reviewed, the Assessment can be updated. Both versions remain visible.

In our pre-submission review work with manuscripts targeting eLife, three patterns generate the most consistent editorial screen failures among the papers we analyze.

Authors who don't understand the model before submitting. eLife's editorial team evaluates whether papers are "suitable for peer review in eLife's reviewed-preprint model." We see authors submitting without recognizing that the peer review will be public and permanently attached to the preprint. Manuscripts where the authors have included speculative claims, preliminary data labeled as preliminary, or acknowledged limitations that would normally be addressed before submission create public review records that follow the paper indefinitely. The model rewards papers that are ready for public evaluation, not papers that are nearly ready. Submitting before the data package is complete is riskier at eLife than at traditional journals.

Papers submitted outside eLife's life-science scope. eLife covers biomedical and life sciences. We observe manuscripts from chemistry, physics, and materials science submitted to eLife because of its open-access model and fee structure. The editorial screen rejects these quickly. The scope boundary is more important at eLife than at multidisciplinary journals because eLife's reviewing editors are selected specifically for biological expertise.

Significance framing that describes technical achievement rather than biological importance. eLife's eLife Assessment uses specific vocabulary: landmark, fundamental, important, valuable, useful. We find that manuscripts where the cover letter argues methodological innovation without connecting to biological significance receive "useful" or "valuable" assessments rather than "fundamental" or "landmark" assessments. The assessment vocabulary reflects the editorial filter. A new imaging method is not significant to eLife unless the biological insight it enables is stated clearly and specifically. Framing the contribution as a tool rather than a discovery misaligns with how eLife evaluates significance.

SciRev author-reported data confirms eLife's 14-day median to editorial screening decision. An eLife biological significance and data completeness check can assess whether your manuscript's biological significance framing and data completeness meet eLife's bar before you submit.